Updates in HER2-Positive Metastatic Breast Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 588
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2021 AND VI 35 AND IP 9
Results: 13
1
2
Experts Discuss Personalized ctDNA Assays to Predict Immunotherapy Response.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 592
- By:
- Publication type:
- Article
3
Transforming Outcomes in Multiple Myeloma With Antibody-Based Regimens.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 598
- By:
- Publication type:
- Article
4
Management of Chemotherapy-Ineligible Acute Myeloid Leukemia: Beyond Hypomethylating Agent Monotherapy.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 594
- By:
- Publication type:
- Article
5
Advanced Urothelial Cancer: Updates in Frontline Systemic Therapy.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 584
- By:
- Publication type:
- Article
6
EXPERT COMMENTARY ON THE PRODUCT PROFILE OF Margetuximab for HER2-Positive Breast Cancer [including commentary by Sandra Cuellar].
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 573
- Publication type:
- Article
7
The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 553, doi. 10.46883/onc.2021.3509.0553
- By:
- Publication type:
- Article
8
Addressing Stress and Burnout in Hematology/Oncology Physicians.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 520, doi. 10.46883/onc.2021.3509.0520
- By:
- Publication type:
- Article
9
The COLOMATE Platform: An Indispensable Initiative Promoting True Precision Oncology Prioritized for Patients With Cancer--From "MAYBE" to "MUST BE".
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 554, doi. 10.46883/onc.2021.3509.0554
- By:
- Publication type:
- Article
10
Oligoprogression After Immunotherapy and Targeted Therapy in Metastatic Melanoma.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 562, doi. 10.46883/onc.2021.3509.0562
- By:
- Publication type:
- Article
11
Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer: Comparison of Conventional Variables in Risk Stratification.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 528, doi. 10.46883/onc.2021.3509.0528
- By:
- Publication type:
- Article
12
Investigators Look Past Standard Immunotherapy for Additional Lung Cancer Solutions.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 526
- By:
- Publication type:
- Article
13
Scientific Progress Involves Research Findings With Missed End Points.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 519
- By:
- Publication type:
- Article